FDA Drug Application (076405) for TRI-LEGEST 21 by BARR

Back to FDA Applications sponsored by BARR

Application Number076405
Product Number001
FormTABLET;ORAL-21
Dosage0.02MG,0.03MG,0.035MG;1MG,1MG,1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRI-LEGEST 21
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE ACETATE56


Back to FDA Applications sponsored by BARR